Action 1548 GENSCRIPT BIOTECH CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Genscript Biotech Corporation

Actions

1548

KYG3825B1059

Temps Différé Hong Kong S.E.
Autres places de cotation
 04:52:05 16/07/2024 		Varia. 5j. Varia. 1 janv.
12,26 HKD -2,23 % Graphique intraday de Genscript Biotech Corporation +36,45 % -38,37 %
10/07 Genscript Biotech utilisera 68 054 actions RSA pour son plan, plus de 425 millions d'actions disponibles dans le cadre du mandat général MT
09/07 Genscript Biotech attribue des actions restreintes dans le cadre d'un plan d'incitation MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
GenScript Biotech Releases 2023 ESG Report, Deepening Green Development Practices, Constructing Sustainable Future Blueprint
AQ
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
BU
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint
PR
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
AQ
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment
AQ
GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance
AQ
Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs
PR
GenScript Announces Its Inaugural Life Science Research Grant Project
PR
San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry
PR
GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector
PR
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry
PR
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
PR
GenScript to Host Biotech Global Forum 2024 during 42nd Annual J.P. Morgan Healthcare Conference
PR
CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum
PR
GenScript Named a BioSpace 2024 Best Place to Work
AQ
GenScript Named a BioSpace 2024 Best Place to Work
PR
GenScript ProBio Partners with Epi Biotech to Advance Hair Loss Antibody Therapy
AQ
GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
PR
GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
PR
GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 1548
  4. Actualités Genscript Biotech Corporation
  5. Communiqués